Cargando…
Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients
INTRODUCTION: Hepatitis C virus (HCV) is the main cause of chronic liver disease, with calamitous complications. Its highest rate is recorded in Egypt. This study investigated whether oxidative stress, immunological chaos and cellular hypoxia are implicated in the pathophysiology of the disease. MAT...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959056/ https://www.ncbi.nlm.nih.gov/pubmed/33747272 http://dx.doi.org/10.5114/aoms.2019.91451 |
_version_ | 1783664904747614208 |
---|---|
author | Almaeen, Abdulrahman Hamdan Alduraywish, Abdulrahman Abdulwahab Mobasher, Maysa Ahmed Almadhi, Omar I. M. Nafeh, Hanan M. El-Metwally, Tarek Hassan |
author_facet | Almaeen, Abdulrahman Hamdan Alduraywish, Abdulrahman Abdulwahab Mobasher, Maysa Ahmed Almadhi, Omar I. M. Nafeh, Hanan M. El-Metwally, Tarek Hassan |
author_sort | Almaeen, Abdulrahman Hamdan |
collection | PubMed |
description | INTRODUCTION: Hepatitis C virus (HCV) is the main cause of chronic liver disease, with calamitous complications. Its highest rate is recorded in Egypt. This study investigated whether oxidative stress, immunological chaos and cellular hypoxia are implicated in the pathophysiology of the disease. MATERIAL AND METHODS: This cross-sectional study aimed to evaluate the changes in blood oxidative stress, cellular hypoxia/angiogenesis and cellular immunological biomarkers in hospital-diagnosed treatment-naïve HCV-infected Upper Egyptian chronic liver disease patients vs. healthy controls (n = 40). The consecutively included patients comprised 120 with normal serum enzymes (HCV-NE) and 130 with high serum enzymes (HCV-HE), along with 120 cirrhotic patients. RESULTS: Oxidative stress biomarkers – malondialdehyde (MDA), total peroxides and oxidative stress index (OSI) – were significantly lower in controls vs. each of the patient groups. Cirrhotic patients presented the highest levels. However, total antioxidants (TAO) showed non-significant differences among the four groups. The cellular hypoxia/angiogenesis biomarkers – lactate, vascular endothelial cell growth factor (VEGF) and its soluble receptor 1 (sVEGFR1) – vs. controls were massively increased in patient groups. VEGF was lowest while sVEGFR1 was highest among cirrhotic patients. Immunological biomarkers, – granulocyte/monocyte-colony stimulating factor (GM-CSF) and total immunoglobulin G (IgG) – were massively increased in patient groups vs. controls. GM-CSF was lowest in HCV-HE and IgG was highest in cirrhotic patients. sVEGFR1 correlated with the progression towards cirrhosis. CONCLUSIONS: Oxidative stress is implicated in the progress of HCV infection with marked induction of cellular hypoxia and dysfunctional angiogenesis, and a futile immunological reaction. sVEGFR1 level correlated with progression towards HCV-induced liver fibrosis. |
format | Online Article Text |
id | pubmed-7959056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-79590562021-03-19 Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients Almaeen, Abdulrahman Hamdan Alduraywish, Abdulrahman Abdulwahab Mobasher, Maysa Ahmed Almadhi, Omar I. M. Nafeh, Hanan M. El-Metwally, Tarek Hassan Arch Med Sci Clinical Research INTRODUCTION: Hepatitis C virus (HCV) is the main cause of chronic liver disease, with calamitous complications. Its highest rate is recorded in Egypt. This study investigated whether oxidative stress, immunological chaos and cellular hypoxia are implicated in the pathophysiology of the disease. MATERIAL AND METHODS: This cross-sectional study aimed to evaluate the changes in blood oxidative stress, cellular hypoxia/angiogenesis and cellular immunological biomarkers in hospital-diagnosed treatment-naïve HCV-infected Upper Egyptian chronic liver disease patients vs. healthy controls (n = 40). The consecutively included patients comprised 120 with normal serum enzymes (HCV-NE) and 130 with high serum enzymes (HCV-HE), along with 120 cirrhotic patients. RESULTS: Oxidative stress biomarkers – malondialdehyde (MDA), total peroxides and oxidative stress index (OSI) – were significantly lower in controls vs. each of the patient groups. Cirrhotic patients presented the highest levels. However, total antioxidants (TAO) showed non-significant differences among the four groups. The cellular hypoxia/angiogenesis biomarkers – lactate, vascular endothelial cell growth factor (VEGF) and its soluble receptor 1 (sVEGFR1) – vs. controls were massively increased in patient groups. VEGF was lowest while sVEGFR1 was highest among cirrhotic patients. Immunological biomarkers, – granulocyte/monocyte-colony stimulating factor (GM-CSF) and total immunoglobulin G (IgG) – were massively increased in patient groups vs. controls. GM-CSF was lowest in HCV-HE and IgG was highest in cirrhotic patients. sVEGFR1 correlated with the progression towards cirrhosis. CONCLUSIONS: Oxidative stress is implicated in the progress of HCV infection with marked induction of cellular hypoxia and dysfunctional angiogenesis, and a futile immunological reaction. sVEGFR1 level correlated with progression towards HCV-induced liver fibrosis. Termedia Publishing House 2020-01-03 /pmc/articles/PMC7959056/ /pubmed/33747272 http://dx.doi.org/10.5114/aoms.2019.91451 Text en Copyright: © 2020 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Clinical Research Almaeen, Abdulrahman Hamdan Alduraywish, Abdulrahman Abdulwahab Mobasher, Maysa Ahmed Almadhi, Omar I. M. Nafeh, Hanan M. El-Metwally, Tarek Hassan Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients |
title | Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients |
title_full | Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients |
title_fullStr | Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients |
title_full_unstemmed | Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients |
title_short | Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients |
title_sort | oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis c treatment-naïve and cirrhotic patients |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959056/ https://www.ncbi.nlm.nih.gov/pubmed/33747272 http://dx.doi.org/10.5114/aoms.2019.91451 |
work_keys_str_mv | AT almaeenabdulrahmanhamdan oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients AT alduraywishabdulrahmanabdulwahab oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients AT mobashermaysaahmed oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients AT almadhiomarim oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients AT nafehhananm oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients AT elmetwallytarekhassan oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients |